周二，Stifel分析师调整了对睡眠障碍医疗设备专业公司ResMed（NYSE:RMD）的展望，将其股价目标从此前的250美元下调至240美元，并维持对该股的"持有"评级。根据InvestingPro数据显示，目前市值342亿美元的ResMed基于公允价值计算略显低估，尽管最近有六位分析师下调了其盈利预期。此次调整基于医生们的见解，他们指出由于GLP-1类药物使用量的增加，持续气道正压通气（CPA ...

Early use of continuous positive airway pressure (CPAP) therapy for sleep apnea could help lower Parkinson's risk, a large ...

Now, researchers at UC San Diego have gotten it approved as the first effective drug therapy for sleep apnea. “Systol ...

Obstructive sleep apnea, or OSA, may increase the risk of Parkinson’s disease, a preliminary new study finds. But researchers say treating OSA quickly may help ...

Between 15% and 20% of U.S. adults over the age of 65 have obstructive sleep apnea (OSA), according to research in the Journal of Clinical Medicine[footnote id = 1]. Continuous positive airway pressur ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

Incidence of Parkinson disease significantly lower with early CPAP treatment, but no reduction seen with late CPAP treatment ...

People with obstructive sleep apnea have an increased risk of Parkinson’s disease, but if started early enough, continuous positive airway pressure (CPAP) may reduce that risk, according to ...

The article covers expert-backed comfort tips for CPAP users, alternative treatments and combining therapy solutions for ...

Obstructive sleep apnea (OSA) was linked with an increased risk of Parkinson's disease, but continuous positive airway ...

周一，高盛将再鼎医药（NASDAQ:ZLAB）和瑞思迈（NYSE:RMD）纳入其亚太区董事重点推荐名单，显示投资银行对这两家公司持积极展望。根据 InvestingPro ...